Literature DB >> 24197553

Evaluation of the quality of life of lupus erythematosus patients with cutaneous lesions in Japan.

M Ishiguro1, H Hashizume, T Ikeda, Y Yamamoto, F Furukawa.   

Abstract

The quality of life (QOL) of lupus erythematosus (LE) patients with skin manifestations is impaired, but little is known about Japanese patients. We assessed whether the skin symptoms in LE are associated with the QOL using the Japanese versions of the Skindex-29 and Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI). In all, 54 LE patients with cutaneous lesions completed the Japanese version of the Skindex-29, and physicians assessed the severity of their eruptions using the CLASI before and after treatment. The QOL of the LE patients was better after the therapeutic intervention using the Skindex-29 questionnaire. We tested several factors for an independent association with the QOL. A significant risk factor for a poor QOL was a female gender in "Functioning" before treatment. In addition, a poor QOL tended to be correlated with a female gender in "Emotions" and older current age in "Symptoms" before treatment, and with a longer duration of SLE in "Functioning" after treatment. In the CLASI analysis, skin manifestation activity in the acute phase correlated with a poor emotional and functional QOL rather than a symptomatic QOL. To the best of our knowledge, this is the first report evaluating the QOL of Japanese LE patients, despite the small cohort.

Entities:  

Keywords:  CLASI; Quality of life; activity; cutaneous lupus erythematosus; damage

Mesh:

Year:  2013        PMID: 24197553     DOI: 10.1177/0961203313509293

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  8 in total

1.  Factors associated with quality of life in cutaneous lupus erythematosus using the Revised Wilson and Cleary Model.

Authors:  Motolani E Ogunsanya; Sung Kyung Cho; Andrew Hudson; Benjamin F Chong
Journal:  Lupus       Date:  2020-09-03       Impact factor: 2.911

2.  Validation and reliability of a disease-specific quality-of-life measure in patients with cutaneous lupus erythematosus.

Authors:  M E Ogunsanya; S K Cho; A Hudson; B F Chong
Journal:  Br J Dermatol       Date:  2019-04-07       Impact factor: 9.302

3.  Validation of the Cutaneous Lupus Erythematosus Disease Area and Severity Index and pSkindex27 for use in childhood-onset systemic lupus erythematosus.

Authors:  Ashwaq AlE'ed; Pinar Ozge Avar Aydin; Nora Al Mutairi; Alhanouf AlSaleem; Hafize Emine Sonmez; Michael Henrickson; Jennifer L Huggins; Seza Ozen; Sulaiman M Al-Mayouf; Hermine I Brunner
Journal:  Lupus Sci Med       Date:  2018-11-17

4.  Understanding the disease burden and unmet needs among patients with cutaneous lupus erythematosus: A qualitative study.

Authors:  M E Ogunsanya; C M Brown; D Lin; F Imarhia; C Maxey; B F Chong
Journal:  Int J Womens Dermatol       Date:  2018-04-13

5.  Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.

Authors:  N Groot; D Shaikhani; Y K O Teng; K de Leeuw; M Bijl; R J E M Dolhain; E Zirkzee; R Fritsch-Stork; I E M Bultink; S Kamphuis
Journal:  Arthritis Rheumatol       Date:  2019-02       Impact factor: 10.995

6.  Quality of life in lupus erythematosus female patients with cutaneous lesions in Antananarivo, Madagascar.

Authors:  Fandresena Arilala Sendrasoa; Tsiory Iarintsoa Razafimaharo; Léophonte Ramily; Mendrika Fifaliana Rakotoarisaona; Malalaniaina Andrianarison; Onivola Raharolahy; Volatantely Tobiniaina Ratovonjanahary; Naina Harinjara Razanakoto; Irina Mamisoa Ranaivo; Lala Soavina Ramarozatovo; Fahafahantsoa Rapelanoro Rabenja
Journal:  Int J Womens Dermatol       Date:  2021-07-31

Review 7.  Influence of Socio-Demographic Factors in Patients With Cutaneous Lupus Erythematosus.

Authors:  Amanda M Walker; Grace Lu; Shari C Clifton; Motolani E Ogunsanya; Benjamin F Chong
Journal:  Front Med (Lausanne)       Date:  2022-07-11

Review 8.  The Burden of Living With Cutaneous Lupus Erythematosus.

Authors:  Cristina Drenkard; Kamil E Barbour; Kurt J Greenlund; S Sam Lim
Journal:  Front Med (Lausanne)       Date:  2022-08-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.